| Name | 1H,3H-Furo[3,4-c]furan, 1,4-bis(3,4-dimethoxyphenyl)tetrahydro-, (1.α.,3a.α.,4.α.,6a.α.)-(-) |
|---|---|
| Synonyms |
Pinoresinol dimethyl ether
Eudesamin,Eudesmin (1S,3aR,4S,6aR)-1,4-Bis(3,4-dimethoxyphenyl)tetrahydro-1H,3H-furo[3,4-c]furan 1H,3H-Furo[3,4-c]furan, 1,4-bis(3,4-dimethoxyphenyl)tetrahydro-, (1S,3aR,4S,6aR)- (7S,7’S,8R,8’R)-eudesmin (1S,3aR,4S,6aR)-1,4-bis(3,4-dimethoxyphenyl)-hexahydrofuro[3,4-c]furan eudesmin |
| Description | Eudesmin ((-)-Eudesmin) impairs adipogenic differentiation via inhibition of S6K1 signaling pathway. Eudesmin possesses diverse therapeutic effects, including anti-tumor, anti-inflammatory, and anti-bacterial activities[1]. |
|---|---|
| Related Catalog | |
| Target |
S6K1[1] |
| In Vitro | Treatment of mesenchymal stem cells (MSCs) with Eudesmin (20, 40, and 80μM) disturbs adipogenesis via suppression of S6K1 signaling pathway. Eudesmin treatment inhibits activation and nuclear translocation of S6K1. S6K1-mediated phosphorylation of H2B at serine 36 (H2BS36p) is reduced upon Eudesmin treatment[1]. |
| References |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 517.3±50.0 °C at 760 mmHg |
| Melting Point | 108.5-109.5℃ |
| Molecular Formula | C22H26O6 |
| Molecular Weight | 386.438 |
| Flash Point | 209.8±30.0 °C |
| Exact Mass | 386.172943 |
| PSA | 55.38000 |
| LogP | 3.08 |
| Vapour Pressure | 0.0±1.3 mmHg at 25°C |
| Index of Refraction | 1.547 |
| Storage condition | 2-8°C |
| Precursor 0 | |
|---|---|
| DownStream 3 | |